share_log

Aptose Biosciences Links With National Cancer Institute to Develop Tuspetinib in MyeloMATCH Trials

Aptose Biosciences Links With National Cancer Institute to Develop Tuspetinib in MyeloMATCH Trials

aptose biosciences与国家癌症研究所合作,在MyeloMATCH试验中开发Tuspetinib
MT Newswires ·  12/03 06:59

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发